| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3821874 | La Presse Médicale | 2006 | 7 Pages |
Abstract
New antituberculosis drugs under development allow us to envision further reduction in the duration of treatment of both drug-resistant and drug-sensitive tuberculosis.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Nicolas Veziris, Alexandra Aubry, Chantal Truffot-Pernot,